NCT01758744View on ClinicalTrials.gov

Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Pulmonary HypertensionCOPD
Interventions
DRUG

Inhaled Treprostinil Therapy

Treprostinil: Inhaled prostanoid therapy

Trial Locations (2)

32209

University of Florida College of Medicine, Jacksonville

80045

University of Colorado Denver, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT01758744 - Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 | Biotech Hunter | Biotech Hunter